Jeong-Dan Cha

Dr. Jeong-Dan Cha


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
YLYoung-Soo Lee
Young-Soo Lee
KJKyeung-Ae Jang
Kyeung-Ae Jang
JCJeong-Dan Cha
Jeong-Dan Cha
Silibinin is a composition of the silymarin group as a hepatoprotective agent, and it exhibits various biological activities, including antibacterial activity. In this study, the antibacterial activities of silibinin were investigated in combination with two antimicrobial agents against oral bacteria. Silibinin was determined with MIC and MBC values ranging from 0.1 to 3.2 and 0.2 to 6.4μg/mL, ampicillin from 0.125 to 64 and 0.5 to 64μg/mL, gentamicin from 2 to 256 and 4 to 512μg/mL, respectively. The ranges of MIC50 and MIC90 were 0.0250.8μg/mL and 0.13.2μg/mL, respectively. The antibacterial activities of silibinin against oral bacteria were assessed using the checkerboard and time-kill methods to evaluate the synergistic effects of treatment with ampicillin or gentamicin. The results were evaluated showing that the combination effects of silibinin with antibiotics were synergistic (FIC index < 0 . 5 ) against all tested oral bacteria. Furthermore, a time-kill study showed that the growth of the tested bacteria was completely attenuated after 26h of treatment with the MBC of silibinin, regardless of whether it was administered alone or with ampicillin or gentamicin. These results suggest that silibinin combined with other antibiotics may be microbiologically beneficial and not antagonistic.

13 April 2011 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
Hyun Kyung KangHyun Kyung Kang
Hyun Kyung Kang
HKHye‐Young Kim
Hye‐Young Kim
JCJeong-Dan Cha
Jeong-Dan Cha